Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 47, Issue 12, Pages 5977-5985
Publisher
SAGE Publications
Online
2019-10-15
DOI
10.1177/0300060519879336
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates
- (2018) Uthaibhorn Singkham-in et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
- (2018) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia
- (2014) A. Nutman et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*
- (2014) Hao-Yuan Lee et al. CRITICAL CARE MEDICINE
- Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
- (2014) P. Poulikakos et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy and Safety of Polymyxins for the Treatment of Acinectobacter baumannii Infection: A Systematic Review and Meta-Analysis
- (2014) Qianqian Liu et al. PLoS One
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2013) G. Kalin et al. INFECTION
- Impact of Appropriate Antimicrobial Therapy on Mortality Associated With Acinetobacter baumannii Bacteremia: Relation to Severity of Infection
- (2012) Y.-T. Lee et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children
- (2012) Warunee Punpanich et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
- (2012) Youn Jeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
- (2012) Ryan K. Shields et al. PLoS One
- Multidrug‐ResistantAcinetobacter baumannii:An Emerging Pathogen among Older Adults in Community Hospitals and Nursing Homes
- (2010) D. M. Sengstock et al. CLINICAL INFECTIOUS DISEASES
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
- (2009) Ronald Gounden et al. BMC INFECTIOUS DISEASES
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
- (2008) Lisa L. Maragakis et al. CLINICAL INFECTIOUS DISEASES
- Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance
- (2008) D. W. Wareham et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Drug treatment for multidrug-resistantAcinetobacter baumanniiinfections
- (2008) Matteo Bassetti et al. Future Microbiology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started